MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


E-Therapeutics finds potential breakthrough Covid-19 treatment

StockMarketWire.com

E-Therapeutics has potentially made new breakthroughs on a potential treatment for Covid-19.

The AIM-listed firm has provided an update on an experimental testing of several molecular compounds and their use against the virus that causes Covid-19.

In particular e-Therapeutics has been analysing these compounds' ability to disrupt the virus's ability to replicate.

The company has said its findings show these compounds 'could be rapidly deployed into clinical trials to treat patients with serious Covid-19 conditions.'



At 1:21pm: (LON:ETX) eTherapeutics PLC share price was 0p at 12.9p


Story provided by StockMarketWire.com